Journal
EXPERT REVIEW OF VACCINES
Volume 10, Issue 11, Pages 1569-1583Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.11.135
Keywords
antigen presentation; cancer; infectious diseases; vaccine; virus-like particles
Categories
Ask authors/readers for more resources
Virus-like particles hold great promise for the development of effective and affordable vaccines. Indeed, virus-like particles are suitable for presentation and efficient delivery of linear as well as conformational antigens to antigen-presenting cells. This will ultimately result in optimal B-cell activation and cross-presentation with both MHC class I and II molecules to prime CD4(+) T-helper as well as CD8(+) cytotoxic T cells. This article provides an update on the development and use of virus-like particles as vaccine approaches for infectious diseases and cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available